Bayesian Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,502
| Closed | -$222K | – | 1079 |
|
|
2024
Q1 | $222K | Buy |
+6,502
| New | +$222K | 0.02% | 634 |
|
|
2019
Q2 | – | Sell |
-13,718
| Closed | -$481K | – | 673 |
|
|
2019
Q1 | $481K | Buy |
13,718
+6,841
| +99% | +$240K | 0.09% | 298 |
|
|
2018
Q4 | $228K | Sell |
6,877
-300
| -4% | -$9.95K | 0.05% | 482 |
|
|
2018
Q3 | $361K | Buy |
7,177
+470
| +7% | +$23.6K | 0.06% | 406 |
|
|
2018
Q2 | $401K | Buy |
+6,707
| New | +$401K | 0.09% | 323 |
|
|
2016
Q4 | – | Sell |
-9,500
| Closed | -$235K | – | 699 |
|
|
2016
Q3 | $235K | Buy |
+9,500
| New | +$235K | 0.15% | 247 |
|